Today: 9 April 2026
GE Vernova stock slips after hours as 2025 ends; dividend date and January earnings in focus
1 January 2026
2 mins read

GE Vernova stock slips after hours as 2025 ends; dividend date and January earnings in focus

NEW YORK, December 31, 2025, 18:41 ET — After-hours

  • GE Vernova shares were down about 0.9% after the bell, tracking a weak year-end tape.
  • Investors are looking to the Jan. 5 dividend record date and late-January earnings timing.
  • Peer grid and power-infrastructure names also edged lower in late trading.

GE Vernova Inc. shares fell in after-hours trading on Wednesday, down 0.9% at $653.57 by 6:41 p.m. ET, or $6.19 below Tuesday’s close. The stock traded between $647.71 and $666.30 during the day, with about 1.26 million shares changing hands.

The slide underscores how sensitive the stock has become to year-end positioning after a sharp run tied to rising electricity demand and data-center buildouts. GE Vernova’s shares have risen more than 370% since the company was spun off from General Electric in 2024, Reuters reported earlier this month. Reuters

With U.S. markets closed on Thursday for New Year’s Day and reopening on Friday, Jan. 2, investors used the final session of 2025 to reduce risk and lock in gains. Traders are also lining up January catalysts, including the next earnings update and the company’s newly increased dividend timeline.

Wall Street ended the year’s final session lower in holiday-thin trade, with the S&P 500 down 0.74%, the Nasdaq off 0.76% and the Dow down 0.63%, according to Reuters. Reuters

Other U.S. companies linked to grid spending and power demand also eased in late trading, including Eaton, Quanta Services, Hubbell and Generac, down roughly 0.6% to 1.6%.

GE Vernova last month raised its medium-term outlook at an investor update, as it flagged long-cycle demand for power equipment. CEO Scott Strazik said, “Electric power will be critical to unlocking economic growth in the decades ahead,” and the company forecast 2026 revenue of $41 billion to $42 billion, with an adjusted EBITDA margin — a profit measure before interest, taxes and some one-offs — of 11% to 13%. It also guided to $4.5 billion to $5.0 billion of free cash flow, or cash left after costs and capital spending, and pointed to “slot reservation agreements,” which reserve manufacturing capacity for future gas-turbine deliveries. GE Vernova

The board also doubled the quarterly dividend to $0.50 a share and raised the share repurchase authorization to $10 billion, the company said. The dividend is payable Feb. 2 to shareholders of record as of Jan. 5. GE Vernova

Even after Wednesday’s slip, the stock remains within its recent range, about 11% below its 52-week high of $731 and far above its 52-week low of $252.25, MarketWatch data showed. MarketWatch

Sell-side targets still imply upside, but they also highlight the valuation debate around the name. MarketWatch data showed an average target price of about $753, with estimates ranging from $485 to $1,000. MarketWatch

The next major check-in will be fourth-quarter results and any update to 2026 demand and margin assumptions. GE Vernova has not announced a reporting date, and Nasdaq’s earnings page lists Jan. 28 as an estimated report date derived from an algorithm. Nasdaq

Into early 2026, investors are likely to focus on order intake in the Power and Electrification units, delivery timing across constrained equipment categories, and signs that data-center-related demand is translating into booked revenue. Updates on wind profitability remain a swing factor for sentiment.

Technically, traders are watching the $650 area after the stock tested it on Wednesday. Holding that level could keep attention on the upper end of the recent range, while a decisive break would shift focus to the next support band from earlier in December.

Stock Market Today

  • Guard Therapeutics Faces Potential Delisting from Nasdaq First North Growth Market
    April 9, 2026, 12:06 PM EDT. Guard Therapeutics International AB has been notified by Nasdaq that it currently fails to meet the active operations requirement, risking delisting by June 17, 2026. The company is exploring a merger or reverse acquisition to satisfy Nasdaq's operational criteria. A transaction structure is expected to be proposed in Q2 2024, allowing Nasdaq to reassess the listing status. If no agreement is reached, the board will recommend voluntary delisting and liquidation, returning available funds to shareholders. Final decisions will be taken by shareholders at a general meeting. Guard Therapeutics focuses on developing therapies for kidney diseases based on the alpha-1-microglobulin protein and is listed under the ticker GUARD.

Latest article

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

9 April 2026
Palantir Technologies dropped about 7% Thursday after Michael Burry said Anthropic was overtaking it in enterprise AI, putting Palantir on track to lose $34 billion in market value. Anthropic reported its annualized revenue run rate had surged past $30 billion and launched new AI tools for businesses. Nearly one in four businesses on Ramp now pays for Anthropic, according to Ramp data. Palantir’s stock still trades at 395 times earnings.
Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

9 April 2026
Salesforce shares hit a new 52-week low Thursday, dropping 3.7% to $169.76 despite reporting 12% revenue growth and strong demand for its AI products. The broader software sector continued to slide, with the S&P 500 software and services index down about $1 trillion since January. Salesforce raised its buyback authorization to $50 billion and increased its dividend to 44 cents a share.
ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

9 April 2026
ServiceNow shares dropped 5.1% to $92.45 by 10:20 a.m. EDT Thursday, hitting a new 52-week low after analysts at Stifel, BTIG, and Goldman Sachs cut price targets citing weak federal spending and limited 2026 growth. The company announced it will integrate AI, data, security, and governance into all products ahead of first-quarter results due April 22.
SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

9 April 2026
SoFi Technologies shares fell 1.9% to $16.18 Thursday after KBW and Wells Fargo cut price targets ahead of first-quarter results due April 29. The moves follow Muddy Waters’ short position and claims of accounting issues, which SoFi denies. Affirm and LendingClub also traded lower. Barclays and other banks have trimmed targets as concerns mount over credit quality and sector valuations.
Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

9 April 2026
Tesla is developing a smaller, cheaper electric SUV to be built first in Shanghai, sources said. The new model would cost less than the Model 3 and be smaller than the Model Y. Tesla produced 408,386 vehicles but delivered only 358,023 in Q1, as U.S. demand weakened and competition increased. Shares fell 0.8% Thursday.
Corcept stock plunges 50% after FDA rejects relacorilant in Cushing’s-related hypertension
Previous Story

Corcept stock plunges 50% after FDA rejects relacorilant in Cushing’s-related hypertension

Cisco stock today: CSCO slips into the close as year-end trading thins, dividend date nears
Next Story

Cisco stock today: CSCO slips into the close as year-end trading thins, dividend date nears

Go toTop